News

Eli Lilly: Don't Bet Against This Biotech Powerhouse

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Eli Lilly and Company (LLY) Releases Q2 2025 Results

Eli Lilly and Company (NYSE:LLY)’s pipeline has been advancing, thanks to positive study results in oncology and ...

Mounjaro for weight loss: What you need to know before starting

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
Pharmaceutical Technology on MSN1d

UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...

Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in ...

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its ...
MyNewsLA.com on MSN2d

Obese Woman Sues Anthem Over Zepbound Coverage Denial

An Anthem Blue Cross subscriber is suing the health insurer, alleging she was wrongfully denied coverage for Zepbound for weight management because she was no longer considered morbidly obese. Alicia ...

Eli Lilly Q2 Preview: Can Mounjaro and Zepbound Keep Delivering?

Eli Lilly & Co. reports Q2 2025 results before the U.S. market opens on August 7. Analysts expect revenue of approximately ...

Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now

Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.